TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 34.9B
Gross Profit 9.8B 28.11%
Operating Income 2.8B 8.13%
Net Income 1.6B 4.58%

Balance Sheet Metrics

Total Assets 111.5B
Total Liabilities 70.7B
Shareholders Equity 40.8B
Debt to Equity 1.73

Cash Flow Metrics

Operating Cash Flow -2.1B
Free Cash Flow -2.3B

Revenue & Profitability Trend

Paradeep Phosphates Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i138.2B56.4B47.7B78.6B37.2B
Cost of Goods Sold i102.3B91.9B107.9B62.8B39.6B
Gross Profit i35.9B-35.5B-60.2B15.8B-2.5B
Gross Margin % i26.0%-62.8%-126.2%20.1%-6.6%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-6.9B5.3B3.4B3.3B
Other Operating Expenses i20.8B7.2B8.2B7.7B1.8B
Total Operating Expenses i20.8B14.1B13.5B11.1B5.0B
Operating Income i10.0B5.2B8.0B5.8B4.7B
Operating Margin % i7.3%9.2%16.7%7.4%12.6%
Non-Operating Items
Interest Income i-62.6M102.6M30.0M20.5M
Interest Expense i3.6B3.0B2.0B855.4M693.5M
Other Non-Operating Income-----
Pre-tax Income i7.5B1.4B4.3B5.3B3.7B
Income Tax i2.0B409.2M1.2B1.4B1.4B
Effective Tax Rate % i26.7%29.1%28.6%25.5%39.1%
Net Income i5.5B999.1M3.0B4.0B2.2B
Net Margin % i4.0%1.8%6.4%5.1%6.0%
Key Metrics
EBITDA i13.7B6.7B8.2B7.1B5.3B
EPS (Basic) i₹6.77₹1.22₹3.90₹6.92₹2.74
EPS (Diluted) i₹6.76₹1.22₹3.90₹6.92₹2.74
Basic Shares Outstanding i815051699814673086779786595575450000814497619
Diluted Shares Outstanding i815051699814673086779786595575450000814497619

Income Statement Trend

Paradeep Phosphates Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i8.7B907.2M430.3M5.4B915.2M
Short-term Investments i8.3B5.3B4.0B5.6B1.2B
Accounts Receivable i25.3B27.2B36.9B9.0B11.6B
Inventory i22.9B18.3B22.4B22.9B9.0B
Other Current Assets6.0B5.8B6.4B-4.8B
Total Current Assets i71.2B57.6B70.2B51.3B29.4B
Non-Current Assets
Property, Plant & Equipment i32.9B268.1M273.1M84.7M65.8M
Goodwill i1.2B1.2B1.2B8.6M773.3M
Intangible Assets i23.6M18.4M17.8M8.6M11.1M
Long-term Investments-----
Other Non-Current Assets644.8M382.9M-1.0K-238.8M
Total Non-Current Assets i40.2B39.0B36.4B27.9B14.8B
Total Assets i111.5B96.6B106.6B79.3B44.2B
Liabilities
Current Liabilities
Accounts Payable i20.3B14.9B19.1B22.7B9.4B
Short-term Debt i37.2B33.2B40.2B24.3B11.4B
Current Portion of Long-term Debt-----
Other Current Liabilities1.2B389.9M245.5M240.1M355.9M
Total Current Liabilities i62.3B52.3B63.9B50.5B23.7B
Non-Current Liabilities
Long-term Debt i6.4B6.9B6.3B5.3B1.1B
Deferred Tax Liabilities i1.8B1.5B1.1B921.8M930.1M
Other Non-Current Liabilities-9.0K--6.6M
Total Non-Current Liabilities i8.4B8.7B7.6B6.5B2.3B
Total Liabilities i70.7B61.0B71.5B57.0B26.0B
Equity
Common Stock i8.2B8.1B8.1B5.8B5.8B
Retained Earnings i-20.1B19.5B16.5B12.5B
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i40.8B35.6B35.0B22.2B18.3B
Key Metrics
Total Debt i43.6B40.1B46.5B29.5B12.5B
Working Capital i9.0B5.3B6.2B798.4M5.7B

Balance Sheet Composition

Paradeep Phosphates Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i7.5B1.4B4.3B5.3B3.7B
Depreciation & Amortization i-----
Stock-Based Compensation i23.7M----
Working Capital Changes i-3.3B12.6B-23.2B-20.2B8.3B
Operating Cash Flow i7.3B16.8B-17.2B-14.4B13.0B
Investing Activities
Capital Expenditures i-3.7B-4.1B-4.4B-6.2B-1.7B
Acquisitions i-0-5.4B-0
Investment Purchases i-62.1B-12.7B-44.1B-54.4B-7.6B
Investment Sales i59.6B13.1B49.5B49.6B6.4B
Investing Cash Flow i-6.2B-3.7B-4.3B-11.0B-2.9B
Financing Activities
Share Repurchases i-----
Dividends Paid i-407.4M-407.4M---
Debt Issuance i4.6B4.6B4.4B5.7B687.9M
Debt Repayment i-131.0B-195.7B-134.0B-46.2B-73.5B
Financing Cash Flow i-122.3B-198.9B-107.0B-29.3B-82.5B
Free Cash Flow i10.2B10.3B-28.1B-6.6B13.3B
Net Change in Cash i-121.1B-185.8B-128.4B-54.7B-72.5B

Cash Flow Trend

Paradeep Phosphates Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 22.86
Forward P/E 20.35
Price to Book 4.50
Price to Sales 1.20
PEG Ratio 0.05

Profitability Ratios

Profit Margin 5.28%
Operating Margin 11.43%
Return on Equity 13.53%
Return on Assets 4.95%

Financial Health

Current Ratio 1.14
Debt to Equity 106.91
Beta -0.16

Per Share Data

EPS (TTM) ₹9.82
Book Value per Share ₹49.91
Revenue per Share ₹183.85

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
paradeep183.0B22.864.5013.53%5.28%106.91
Coromandel 712.9B31.546.4218.41%8.56%6.95
UPL 622.8B3.001.632.01%0.09%105.06
EID Parry India 194.3B18.852.4414.68%2.78%20.91
Sharda Cropchem 89.4B21.283.5712.17%9.29%0.47
Gujarat State 84.5B14.280.704.86%6.50%0.01

Financial data is updated regularly. All figures are in the company's reporting currency.